✦ LIBER ✦

Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumors

✍ Scribed by Donald J. Higby; Donald J. Higby; H. James Wallace Jr.; D. J. Albert; J. F. Holland

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 599 KB
Volume: 33
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197405)33:5<1219::aid-cncr2820330505>3.0.co;2-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early tumor and leukemia response to alk

Early tumor and leukemia response to alkyl-lysophospholipids in a phase I study

✍ Dr Wolfgang E. Berdel; Hermann Schlehe; Ulrich Fink; Berthold Emmerich; Peter A. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

Phase I study of misonidazole and cyclop

Phase I study of misonidazole and cyclophosphamide in solid tumors

✍ Leonard Klein; Cary A. Presant; Charles L. Vogel; Richard Gams; Randall Johnson 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 309 KB

A phase I study of gemcitabine and docet

A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors

✍ David P. Ryan; Thomas J. Lynch; Michael L. Grossbard; Michael V. Seiden; Charles 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I study was initiated to determine the maximum tolerated dose of weekly gemcitabine combined with monthly, fixed-dose docetaxel. ## METHODS. Patients with metastatic solid tumors were treated with docetaxel, 60 mg/m 2 , on Day 1 every 28 days. Gemcitabine was administered on Days 1, 8, and

A phase I study of bortezomib and temozo

A phase I study of bortezomib and temozolomide in patients with advanced solid tumors

✍ J. Portnow; P. Frankel; S. Koehler; P. Twardowski; S. Shibata; C. Martel; R. Mor 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 384 KB

A phase i study of emetine hydrochloride

A phase i study of emetine hydrochloride (nsc 33669) in solid tumors

✍ Michael J. Mastrangelo; Theodor B. Grage; Robert E. Bellet; Arthur J. Weiss 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

Immune responses to AAV in a phase I stu

Immune responses to AAV in a phase I study for Canavan disease

✍ S. W. J. McPhee; C. G. Janson; C. Li; R. J. Samulski; A. S. Camp; J. Francis; D. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract ## Background Canavan disease is a rare leukodystrophy with no current treatment. rAAV‐ASPA has been developed for gene delivery to the central nervous system (CNS) for Canavan disease. This study represents the first use of a viral vector in an attempt to ameliorate a neurodegenerativ